A strong correlation between the percentage of activated splenic cytotoxic T lymphocytes (CD8 + CD69 +) of all live cells in the spleen and the tumor size was observed, indicating that this could be a potential measure for therapy response in this model (Fig. 6C). The gene discussed is CD69; the disease is neoplasm.